Cancer is one of the foremost health problems worldwide and is among the leading causes
of death in the United States. Gastrointestinal tract cancers account for almost one third of …

Simple Summary Pancreatic cancer is a serious ongoing global health burden, with an
overall 5-year survival rate of less than 5%. One major hurdle in the treatment of this disease …

Pancreatic ductal adenocarcinoma (PDAC) presents a 5-year overall survival rate of 11%,
despite efforts to improve clinical outcomes in the past two decades. Therapeutic resistance …

Pancreatic carcinoma (PCa) is a malignant tumor that is highly lethal and lacks an effective
treatment. Although surgical treatment, chemotherapy, and radiotherapy of PCa have …

In the last decades, extensive research has been carried out on the understanding and
treatment of pancreatic cancer. Despite the significant advances in medicine and …

Tissue ablation techniques have emerged as a critical component of modern medical
practice and biomedical research, offering versatile solutions for treating various diseases …

Since its emergence as a diagnostic modality in the 1980s, endoscopic ultrasound (EUS)
has provided the clinician profound access to gastrointestinal organs to aid in the direct …

Pancreatic malignancy is still the most lethal gastrointestinal malignancy. It has a very poor
prognosis with low survival rate. Surgery is still the main treatment option for pancreatic …

Thermal ablation, including microwave ablation, has become increasingly important in the
management of many solid tumors, including primary and metastatic tumors of the liver …

Simple Summary The 5-year overall survival rate for all stages of pancreatic cancer is
relatively low at about only 6%. As a result of this exceedingly poor prognosis, new research …